Rocket Pharmaceuticals RCKT
NASDAQ RCKT
$2.48 +0.03 (+1.22%)
At close: Nov 11, 2026 · 4:00 PM EST

Rocket Pharmaceuticals (RCKT) Total Debt (2013 - 2021)

Updated

Rocket Pharmaceuticals' Total Debt came in at $5.1 million for Q2 2021, up 2.3% from the prior quarter.

Analysis

Rocket Pharmaceuticals (RCKT) Total Debt (2013 - 2021) Analysis & Trends

At the end of FY2020, Rocket Pharmaceuticals' Total Debt was $4.88 million.

  • The Q2 2021 figure represents the highest quarterly Total Debt since Q4 2014.
  • Business Quant data shows RCKT's Total Debt at $4.99 million (Q1 2021), $4.88 million (Q4 2020) and $4.77 million (Q3 2020) in the three quarters before Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 49.50 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 44.65 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 80.90 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 53.78 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -6.68 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 54.01 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 26.23 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 62.67 Bn
10 Rocket Pharmaceuticals 268.37 Mn -15.33 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 5.10 Mn
Mar 31, 2021 4.99 Mn
Dec 31, 2020 4.88 Mn
Sep 30, 2020 4.77 Mn
Dec 31, 2014 5.61 Mn
Dec 31, 2013 6.81 Mn
API Access

Rocket Pharmaceuticals Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=RCKT&period=max&api_key=YOUR_API_KEY